Barriers to a software reminder system for risk assessment of stroke in atrial fibrillation: a process evaluation of a cluster randomised trial in general practice

Barriers to a software reminder system for risk assessment of stroke in atrial fibrillation: a process evaluation of a cluster randomised trial in general practice

BACKGROUND:Oral anticoagulants reduce the risk of stroke in patients with atrial fibrillation (AF), but are underused. AURAS-AF (AUtomated Risk Assessment for Stroke in AF) is a software tool designed to identify eligible patients and promote discussions within consultations about initiating anticoa...

Description complète

Détails bibliographiques
Auteurs principaux:	Holt, T, Dalton, A, Kirkpatrick, S, Hislop, J, Marshall, T, Fay, M, Qureshi, N, Lasserson, D, Kearley, K, Mollison, J, Yu, L, Fitzmaurice, D, Hobbs, F
Format:	Journal article
Langue:	English
Publié:	Royal College of General Practitioners 2018

Documents similaires

Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial.
par: Holt, T, et autres
Publié: (2013)

Automated software system to promote anticoagulation and reduce stroke risk: Cluster-randomized controlled trial
par: Holt, T, et autres
Publié: (2017)

Anticoagulant management in patients with atrial fibrillation.
par: Fitzmaurice, D, et autres
Publié: (2009)

ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - EXPERT SOFTWARE MAY BE THE ANSWER
par: Fitzmaurice, D, et autres
Publié: (1994)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
par: Mant, J, et autres
Publié: (2007)

Research into practice: management of atrial fibrillation in general practice.
par: Fitzmaurice, D, et autres
Publié: (2014)

Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors
par: Kearley, K, et autres
Publié: (2014)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
par: Mant, J, et autres
Publié: (2003)

Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.
par: Mant, J, et autres
Publié: (2007)

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
par: Mavaddat, N, et autres
Publié: (2014)

Warfarin versus aspirin for prevention of cognitive decline in an elderly community population with atrial fibrillation (the BAFTA Study): a randomised controlled trial
par: Mavaddat, N, et autres
Publié: (2013)

Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial.
par: Fitzmaurice, D, et autres
Publié: (2007)

Atrial fibrillation: is screening effective in identifying patients at risk of stroke?
par: McCahon, D, et autres
Publié: (2014)

Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".
par: Mavaddat, N, et autres
Publié: (2014)

An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.
par: Apenteng, P, et autres
Publié: (2013)

A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]
par: Swancutt, D, et autres
Publié: (2004)

Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial.
par: Holt, T, et autres
Publié: (2010)

Automated electronic reminders to facilitate primary cardiovascular disease prevention: Randomised controlled trial
par: Holt, T, et autres
Publié: (2010)

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
par: Hobbs, F, et autres
Publié: (2005)

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
par: Hobbs, F, et autres
Publié: (2005)

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
par: F Hobbs, et autres
Publié: (2005-10-01)

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
par: Jowett, S, et autres
Publié: (2011)

Screening of older patients for atrial fibrillation in general practice: Current evidence and its implications for future practice
par: Matthew R. Fay, et autres
Publié: (2017-10-01)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
par: Fletcher Kate, et autres
Publié: (2003-08-01)

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
par: Apenteng, P, et autres
Publié: (2018)

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
par: Apenteng, P, et autres
Publié: (2018)

33Patterns of antithrombotic therapy in relation to type of atrial fibrillation: insights from the UK cohort of the global GARFIELD registry.
par: Apenteng, P, et autres
Publié: (2014)

Stroke prevention in atrial fibrillation
par: Hobbs, F
Publié: (2003)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
par: Hobbs, F, et autres
Publié: (2011)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial
par: Hobbs, R, et autres
Publié: (2011)

A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
par: Hurley, V, et autres
Publié: (2007)

Should we screen for atrial fibrillation?
par: Lown, M, et autres
Publié: (2017)

Treatment pathways for patients with atrial fibrillation.
par: Hodgkinson, J, et autres
Publié: (2012)

Evolving antithrombotic treatment patterns in patients with newly diagnosed atrial fibrillation: UK findings from the GARFIELD-AF registry
par: Apenteng, P, et autres
Publié: (2016)

ExACT: Extended anticoagulation treatment for VTE: a randomised trial
par: Fitzmaurice, D, et autres
Publié: (2011)

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
par: van Walraven, C, et autres
Publié: (2009)

Screening for atrial fibrillation: A call for evidence
par: Jones, N, et autres
Publié: (2019)

Protective effect of uridine on atrial fibrillation: a Mendelian randomisation study
par: Xintian Xu, et autres
Publié: (2023-11-01)

Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom.
par: Mohammed A Mohammed, et autres
Publié: (2013-01-01)

A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]
par: Raftery James, et autres
Publié: (2004-07-01)